Pilot Study of Nitrate-rich Beetroot Juice Supplementation in Patients With Idiopathic Pulmonary Fibrosis (IPF)

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-85
SponsorUniversity Hospital Southampton NHS Foundation Trust

About this trial

Idiopathic pulmonary fibrosis (IPF) is a type of scarring (fibrotic) lung disease. Reduced exercise capacity is a key symptom experienced by patients. In previous research the investigators identified that an interval-based exercise programme led to significant improvements in exercise capacity (Wallis et al Antioxidants. 2023).

An unexpected finding was that in patients with IPF, exercise led to a reduction in blood nitrite concentrations an observation the investigators did not see in non-affected individuals. Research has identified that nitrite concentrations are expected to increase after exercise and the size of this increase is related to an individual's exercise capacity. There is also evidence from healthy individuals and patients with chronic obstructive pulmonary disease (COPD) that nitrate supplementation (a source of nitrite) improves response to exercise training. However, in both these groups an exercise-induced fall in blood nitrite concentrations has not been observed. Hence our finding of an exercise-induced fall in blood nitrite levels in IPF patients suggest that they may be especially sensitive to supplementation with nitrate, commercially available as nitrate-rich beetroot juice (NRBJ).

This current study investigates this in a pilot placebo-controlled, double-blind, randomised, cross-over study of NRBJ on exercise capacity in IPF patients.

Aims In patients with IPF

* Quantify the effect of nitrate supplementation on exercise capacity * Determine the effect of nitrate supplementation on blood markers of nitric oxide production/metabolism. * Determine the effect of nitrate supplementation on forearm blood flow. Sample size: n=8 IPF patients, aged 18-85years and medical research breathlessness scale 1-3 Intervention: 3-days (two-times daily) NRBJ or nitrate-depleted placebo juice (both commercially available) with subsequent constant-load exercise test (Primary outcome). Following at least 1 week wash-out period participants will cross-over and repeat.

A cohort (n=8) of age, sex-matched controls without IPF will be enrolled for comparison of forearm blood flow and pre-exercise venous blood samples for biomarkers comparison only.

Number of sites: 1

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Medical Research Council (MRC) breathlessness grade 1-3

Judged clinically stable for 3 months prior to recruitment by the investigator.

Disqualifiers

Baseline spirometry with FEV1/FVC ratio < 0.7.

Neoplastic disease undergoing treatment or active follow up.

Presence of infection or exacerbation requiring hospitalization, within last 3 months.

Current tobacco smoker or use of nicotine containing vapes (within 3 months)

Trial design

Design model

Crossover

Treatments tested in this trial

  • nitrate-rich beetroot juice (70ml with approx. 400 mg nitrate) twice a day for 3 days

    Dietary supplement

    commercially available beetroot juice dietary nitrate supplement

Treatment groups

16 Participants
are divided into 2 treatment groups
Group A: Group AExperimental treatment 1 intervention
Group B: Group BPlacebo comparator 1 intervention

Trial outcomes

Primary outcomes

1

endurance time

fixed-load static cycle ergometry test

Time frame
From end of treatment period 1 to end of treatment period 2 (minimum 10 days)

Secondary outcomes

1

plasma nitrate and nitrite concentrations

venous blood samples

Time frame
From end of treatment period 1 to end of treatment period 2 (minimum 10 days)
2

forearm blood flow

venous occlusion digital thermal imaging

Time frame
From end of treatment period 1 to end of treatment period 2 (minimum 10 days)

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University Hospital Southampton NHS Foundation Trust

Lead sponsor

NIHR Southampton Respiratory Biomedical Research Centre

Collaborator

Asthma, Allergy and Inflammation Research (AAIR) Charity

Collaborator